The efficacy of Dulaglutide for the coronary plaque in patiENts with type 2 diabetes mellitus Evaluated By optical coherence tomography: single-center, randomized, open-label, parallel group study.
Not Applicable
- Conditions
- Coronary artery disease
- Registration Number
- JPRN-UMIN000039095
- Lead Sponsor
- Kobe University, department of cardiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Type 1 diabetes mellitus. (2)Hemodialysis patients (3)Patients who have received one or more doses of glucagon-like peptide 1 receptor agonist. (4)Patients with allergic drug hypersensitivity to drugs to be used. (5)Patients who conflict with any of the warning contraindications listed. (6)Pregnant women and pregnant or lactating patients. (7)Familial hypercholesterolemia homozygote. (8)Patients with a history of gastrointestinal injury, pancreatitis and ileus. (9)Others Patients judged inappropriate by the doctor in charge of this exam.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of the Lipid Index calculated by OCT from baseline to treatment evaluation (week 38).
- Secondary Outcome Measures
Name Time Method